Journal
/
/
An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers
JoVE Journal
Medicine
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Medicine
An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers
DOI:

06:34 min

December 01, 2017

, , , , , ,

Chapters

  • 00:05Title
  • 00:54Hemagglutination Inhibition (HI) Assay
  • 03:28Results: Representative Vacination-induced Antibody Responses Against Influenza
  • 05:11Conclusion

Summary

Automatic Translation

The presented protocols describe how to perform a hemagglutination inhibition assay to quantify influenza-specific antibody titers from serum samples of influenza vaccine recipients. The first assay determines optimal viral antigen concentrations by hemagglutination. The second assay quantifies influenza-specific antibody titers by hemagglutination inhibition.

Related Videos

Read Article